AtriCure ATRC
NASDAQ ATRC
$53.01 -0.02 (-0.04%)
As of: Sep 10, 2026 · 3:59 PM EDT

AtriCure (ATRC) Non-Current Assets (2010 - 2026)

AtriCure's (ATRC) quarterly Non-Current Assets came in at $331.1 million in Q2 2026, down 1.92% year-over-year from $337.6 million in Q2 2025, and little changed quarter-over-quarter from $330.3 million in Q1 2026.

Analysis

AtriCure (ATRC) Non-Current Assets (2010 - 2026) Analysis & Trends

AtriCure (ATRC) has reported Non-Current Assets for 17 consecutive years, with $331.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 1.92% year-over-year to $331.1 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 2.76% decrease from a year earlier, with the FY2025 full-year figure at $331.7 million, down 2.88% from the prior year.
  • Non-Current Assets was $331.1 million for Q2 2026 at AtriCure, roughly flat from $330.3 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $385.4 million in Q1 2022 and troughed at $330.3 million in Q1 2026.
  • A 5-year average of $349.2 million and a median of $345.3 million in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets declined 18.04% in 2022 and advanced 0.47% in 2024, its largest moves.
  • Over 5 years, Non-Current Assets stood at $370.2 million in 2022, then declined by 6.09% to $347.7 million in 2023, then fell by 1.78% to $341.5 million in 2024, then fell by 2.88% to $331.7 million in 2025, then slipped by 0.17% to $331.1 million in 2026.
  • The last three Non-Current Assets figures came in at $331.1 million (Q2 2026), $330.3 million (Q1 2026), and $331.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 68.92 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 7.05 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 2.37 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 8.29 Bn
10 AtriCure 2.58 Bn 2.41 Bn 118.63 Mn 331.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 331.11 Mn
Mar 31, 2026 330.30 Mn
Dec 31, 2025 331.66 Mn
Sep 30, 2025 334.33 Mn
Jun 30, 2025 337.59 Mn
Mar 31, 2025 340.15 Mn
Dec 31, 2024 341.50 Mn
Sep 30, 2024 345.78 Mn
Jun 30, 2024 344.42 Mn
Mar 31, 2024 346.40 Mn
Dec 31, 2023 347.69 Mn
Sep 30, 2023 347.55 Mn
Jun 30, 2023 356.20 Mn
Mar 31, 2023 344.78 Mn
Dec 31, 2022 370.23 Mn
Sep 30, 2022 369.63 Mn
Jun 30, 2022 381.22 Mn
Mar 31, 2022 385.38 Mn
Dec 31, 2021 419.24 Mn
Sep 30, 2021 417.26 Mn